Anaconda Biomed Receives IDE Approval to Initiate Enrollment in the ATHENA Study

by Ysios Capital

Anaconda Biomed S.L. has announced that it has received conditional IDE approval from the U.S. Food and Drug Administration to begin the ATHENA study of its ANA Funnel Catheter. The prospective, rando...

Read more

ANACONDA BIOMED S.L. secures €20 Million round of funding

by Anaconda BioMed

​Anaconda​ Biomed S.L., a medical technology company developing next-generation th​rombectomy systems for the treatment of ischemic stroke, has closed €20 million in new funding. The funding w...

Read more

Anaconda announces first-in-human study of next-generation thrombectomy system

by CATALONIA.HEALTH

Anacon​da Biomed, a medical technology company developing a next-generation​ thrombectomy system for the treatment of ischemic stroke, has announced the completion of initial patient cases in a fi...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream